✦ LIBER ✦

Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

✍ Scribed by Wiernik, Andres; Sperr, Wolfgang R.; Weisdorf, Daniel; Valent, Peter; Ustun, Celalettin

Book ID: 120056247
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 475 KB
Volume: 88
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mosaic Down syndrome-associated acute my

Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy

✍ Kazuko Kudo; Asahito Hama; Seiji Kojima; Ruriko Ishii; Akira Morimoto; Fumio Bes 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 206 KB

High-dose cytarabine and mitoxantrone in

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia

✍ Schlenk, R F; Germing, U; Hartmann, F; Glasmacher, A; Fischer, J T; del Valle y 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Intermediate dose cytarabine plus mitoxa

Intermediate dose cytarabine plus mitoxantrone is as effective as, but more toxic than, low-dose cytarabine for postremission therapy among older patients with primary acute myeloid leukemia

✍ Matt Kalaycio 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Clofarabine plus low-dose cytarabine fol

Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients

✍ Stefan Faderl; Farhad Ravandi; Xuelin Huang; Xuemei Wang; Elias Jabbour; Guiller 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

Bortezomib Added to Daunorubicin and Cyt

Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502

✍ Attar, E. C.; Johnson, J. L.; Amrein, P. C.; Lozanski, G.; Wadleigh, M.; DeAngel 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 230 KB

Salvage therapy with endostatin, low-dos

Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia

✍ Baijun Fang; Yuzhang Liu; Jian Zhou; Yanan Li; Yongping Song 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB